The full results of the ANNEXA-I trial have continued to show mixed effects of the factor Xa inhibitor reversal agent, andexanet (Andexxa/Ondexxya, AstraZeneca), in patients with intracerebral ...
CSL Behring announced that the FDA has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of ...
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced that Annals of Emergency Medicine, the journal of the American College of ...
A rheumatoid factor (RF) test detects rheumatoid factor, a type of antibody (proteins that fight off harmful substances) in your blood. RF antibodies sometimes attack healthy cells and tissues, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback